Weekly Spotlight - 31.10.24

In the News

Allergic Contact Dermatitis: A Misdiagnosis Journey to Recovery

A woman in her 50s was misdiagnosed with dermatomyositis due to a rash and fatigue. Her symptoms were actually caused by an allergy to paraphenylenediamine, found through patch testing. After stopping hair dye use and applying topical steroids, her symptoms resolved, highlighting the importance of thorough medical history.

Biosimilar Adalimumab Retention Unaffected by Comorbidities in Rheumatic Diseases

Comorbidities do not significantly affect the retention of biosimilar adalimumab in patients with inflammatory rheumatic diseases. After six months, most patients continued treatment, showing promising results. While disease activity and physical function were worse in those with comorbidities, retention rates remained stable, offering hope for effective management.

MRI Biomarkers Advance Neuromuscular Disease Research

AMRA Medical's recent study highlights the effectiveness of MRI-based biomarkers in tracking disease progression and treatment response in sporadic inclusion body myositis. This research, published in Muscle & Nerve, underscores the potential of these biomarkers to enhance neuromuscular disease trials, offering hope for improved patient outcomes.

Coping with Dermatomyositis: Embrace Acceptance, Seek Support, Gain Knowledge

Dorothy Vetrano shares her journey with dermatomyositis, emphasising the importance of A.S.K.: Accept, Seek, and Knowledge. Acceptance of the condition, seeking positive lifestyle changes, and gaining knowledge to manage health are key. Her supportive approach encourages active participation in medical care and finding strength in community and self-care.

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!